Atomo Diagnostics Ltd (at1) Logo

Atomo Diagnostics Ltd (AT1)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

AT1 ASX Chart

Snapshot

Atomo is an Australian medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market. Atomo's patented devices simplify testing procedures and enhance usability for professional users and untrained self-testers.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -31.85%
vs ASX 200 (1yr) -22.73%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,666 of 2,358
Sector Rank 162 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies HMD / CBL / CDX
EPS -$0.012
DPS $0.00
Book Value Per Share $0.018

Broker Consensus

AT1 is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Leichhardt NSW 2040
Website www.atomodiagnostics.com
Registry BoardRoom
Auditor BDO Audit Pty Ltd
Date Listed 16 Apr 2020

Upcoming Calendar (Forecasted)

Date Event
15/11/2024 AGM

Former Company Names

  • Atomo Diagnostics Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

AT1 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
03/08/23 John Kelly Expiry 666,666 $0.03 $19,999 Options expired
11/04/23 Curt LaBelle Expiry 1,200,000 $0.04 $48,000 Options expired
11/04/23 John Keith Expiry 1,200,000 $0.04 $48,000 Options expired
27/10/22 John Kelly Issued 666,666 $0.02 $13,333 Issue of options
25/08/22 John Kelly Expiry 666,667 $0.073 $48,666 Options expired
06/04/22 Curt LaBelle Expiry 1,200,000 $0.12 $144,000 Options expired
06/04/22 John Keith Expiry 2,400,000 $0.12 $288,000 Options expired
03/11/21 John Kelly Expiry 666,667 $0.265 $176,666 Options expired
03/11/21 John Kelly Issued 333,333 $0.265 $88,333 Issue of options
03/11/21 John Kelly Sell +1,040,000 $0.276 ($286,896) As advised by the company
09/04/21 Curt LaBelle Buy +960,000 $0.156 $150,000 Exercise of options
09/04/21 Curt LaBelle Exercise 960,000 $0.156 $150,000 Exercise of options
09/04/21 Curt LaBelle Buy +240,000 $0.156 $37,500 Exercise of options
09/04/21 Curt LaBelle Exercise 240,000 $0.156 $37,500 Exercise of options

Director Interests

The current holdings of AT1 directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
John Kelly 30/06/2024 72,490,248 N/A 666,666 N/A
John Keith 30/06/2024 3,261,056 N/A N/A N/A
Paul Kasian 30/06/2024 N/A 100,000 N/A N/A
Cheri Walker 15/11/2022 0 N/A N/A N/A
Deborah Neff 15/09/2021 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 13, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
GZ Family Holdings Pty Ltd 79,787,536 12.48%
Dalraida Holdings Pty Limited 65,120,000 10.19%
Global Health Investment Fund 64,811,280 10.14%
Mr Xiaoyi Lin 11,880,000 1.86%
Grand Challenges Canada 11,390,824 1.78%
Liverbird Pty Ltd 10,931,653 1.71%
Australia West Holdings Pty 10,500,000 1.64%
Australia North Holdings Pty 9,580,000 1.50%
ID&E Pty Ltd 9,032,248 1.41%
Mark Andrew Smith 7,790,224 1.22%
Mr Ian Fredrick Johnson 7,506,080 1.17%
John Michael Kelly 7,370,248 1.15%
Leo James Lynch 7,321,121 1.15%
Citicorp Nominees Pty Limited 6,355,684 0.99%
Mr Ankur Choudhary 5,887,126 0.92%
Ruth Karen Devney 5,626,408 0.88%
Sokolov Pty Ltd 4,031,888 0.63%
H & L Management Pty Ltd 4,000,000 0.63%
Rue Des Rocs Pty Ltd 3,800,000 0.59%
Miss Lisa Marie Mackenzie 3,351,968 0.52%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 277 2,787 1,118 2,080 588 6,850

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
John Kelly 13/08/2024 72,490,248 11.34
GZ Family Holdings Pty Ltd 13/08/2024 79,787,536 12.48
Global Health Investment Fund I LLC 13/08/2024 64,811,280 10.14

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.025 28 June
2023 $0.022 30 June
2022 $0.056 30 June
2021 $0.185 30 June
2020 $0.34 30 June
AT1 Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.